All In Biotech

Free tool

FAERS Monitor: Lamictal Xr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022509 or its brand name (Lamictal Xr, Lamotrigine). Reports on generic versions are filed under their own applications.

Reports

132,921

Serious

95,830

72% of reports

Hospitalization

40,863

Death reported

11,516

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective10,467
  • rash8,737
  • seizure6,882
  • nausea6,498
  • off label use6,324
  • fatigue6,299
  • dizziness6,140
  • headache5,868
  • depression5,290
  • vomiting4,887
  • somnolence4,571
  • drug interaction4,529
  • pyrexia4,529
  • anxiety4,518
  • toxicity to various agents4,374

Reports by year received

View as table
YearReports
20042,016
20053,052
20063,557
20073,880
20082,377
20094,901
20103,808
20114,992
20125,304
20134,731
20145,234
20157,311
20167,568
20177,268
20188,262
20198,660
20207,763
20217,290
20226,688
20237,031
20247,715
20257,912
20265,600

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,921,238 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal6,88210.09.752,458
drug interactionSignal4,5294.64.512,574
toxicity to various agentsSignal4,3744.24.110,415
depressionSignal5,2903.73.610,496
somnolenceSignal4,5713.73.58,685
rashSignal8,7373.23.213,348
anxietySignal4,5182.52.54,193
pyrexiaSignal4,5292.12.02,566
dizziness6,1402.01.92,919
vomiting4,8871.71.61,271
headache5,8681.51.4950
nausea6,4981.31.3468
fatigue6,2991.31.3403
drug ineffective10,4671.31.2589
off label use6,3241.11.1118

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.